top of page
  • Writer's pictureLaurent DECORY

Pharma & MedTech launches in a post-Covid world

Updated: May 24, 2020

Beyond launch events and face-to-face push, how should Pharma & MedTech launch products in a post-Covid world ? Novartis has recently experienced a digital-only soft launch for its lung cancer med Tabrecta, in the middle of the pandemic. A Hybrid approach might be the best option however, combining in the best way digital and in-person activities. While it more easy than ever before to spread information digitally, the human relationship and trust between HCPs and commercial teams still has a future. And in a post-covid world, product launches will require a coordinated amplification (rather than replacement) of this relationship through digital channels. Optimizing Launch Readiness and Execution Plan in an omni-channel world is among BlueJet Consulting expertise areas. Contact us for a free diagnosis. #PostCovid19 #productlaunch Continue reading

6 views0 comments
bottom of page